Literature DB >> 26694904

Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study.

Noam D Kitrey1, Ilan Gruenwald2, Boaz Appel2, Arik Shechter3, Omar Massarwa2, Yoram Vardi4.   

Abstract

PURPOSE: We performed sham controlled evaluation of penile low intensity shock wave treatment effect in patients unable to achieve sexual intercourse using PDE5i (phosphodiesterase type 5 inhibitor).
MATERIALS AND METHODS: This prospective, randomized, double-blind, sham controlled study was done in patients with vasculogenic erectile dysfunction who stopped using PDE5i due to no efficacy. All patients had an erection hardness score of 2 or less with PDE5i. A total of 58 patients were randomized, including 37 treated with low intensity shock waves (12 sessions of 1,500 pulses of 0.09 mJ/mm(2) at 120 shock waves per minute) and 18 treated with a sham probe. In the sham group 16 patients underwent low intensity shock wave treatment 1 month after sham treatment. All patients were evaluated at baseline and 1 month after the end of treatment using validated erectile dysfunction questionnaires and the flow mediated dilatation technique for penile endothelial function. Erectile function was evaluated while patients were receiving PDE5i.
RESULTS: In the low intensity shock wave treatment group and the sham group 54.1% and 0% of patients, respectively, achieved erection hard enough for vaginal penetration, that is an EHS (Erection Hardness Score) of 3 (p <0.0001). According to changes in the IIEF-EF (International Index of Erectile Function-Erectile Function) score treatment was effective in 40.5% of men who received low intensity shock wave treatment but in none in the sham group (p = 0.001). Of patients treated with shock waves after sham treatment 56.3% achieved erection hard enough for penetration (p <0.005).
CONCLUSIONS: Low intensity shock wave treatment is effective even in patients with severe erectile dysfunction who are PDE5i nonresponders. After treatment about half of them were able to achieve erection hard enough for penetration with PDE5i. Longer followup is needed to establish the place of low intensity shock wave treatment in these challenging cases.
Copyright © 2016 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  erectile dysfunction; high energy shock waves; phosphodiesterase 5 inhibitors; questionnaires; testis

Mesh:

Substances:

Year:  2015        PMID: 26694904     DOI: 10.1016/j.juro.2015.12.049

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  33 in total

1.  Sexual dysfunction: Shockwaves for erectile dysfunction.

Authors:  Rebecca Kelsey
Journal:  Nat Rev Urol       Date:  2015-12-31       Impact factor: 14.432

2.  Is there a role for extracorporeal shock wave therapy for erectile dysfunction unresponsive to phosphodiesterase type 5 inhibitors?

Authors:  Zi-Jun Zou; Zhi-Hong Liu; Liang-You Tang; Yi-Ping Lu
Journal:  World J Urol       Date:  2016-07-22       Impact factor: 4.226

Review 3.  The Basic Physics of Waves, Soundwaves, and Shockwaves for Erectile Dysfunction.

Authors:  Jonathan Elliott Katz; Raul Ivan Clavijo; Paul Rizk; Ranjith Ramasamy
Journal:  Sex Med Rev       Date:  2019-11-14

Review 4.  Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough?

Authors:  Mikkel Fode; Georgios Hatzichristodoulou; Ege Can Serefoglu; Paolo Verze; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2017-07-25       Impact factor: 14.432

5.  Canadian Urological Association guideline: Erectile dysfunction.

Authors:  Trustin Domes; Borna Tadayon Najafabadi; Matthew Roberts; Jeffrey Campbell; Ryan Flannigan; Phil Bach; Premal Patel; Gavin Langille; Yonah Krakowsky; Philippe D Violette
Journal:  Can Urol Assoc J       Date:  2021-10       Impact factor: 1.862

6.  The Efficacy of Li-ESWT Combined With VED in Diabetic ED Patients Unresponsive to PDE5is: A Single-Center, Randomized Clinical Trial.

Authors:  Rongzhen Tao; Jianhuai Chen; Dujian Wang; Yunpeng Li; Jun Xiang; Lei Xiong; Junbiao Ji; Jie Wu; Shuang Zhou; Chunping Jia; Jianlin Lv; Jie Yang; Qinglai Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

7.  Penile low intensity shock wave treatment for PDE5I refractory erectile dysfunction: a randomized double-blind sham-controlled clinical trial.

Authors:  Jose Vinay; Daniel Moreno; Osvaldo Rajmil; Eduard Ruiz-Castañe; Josvany Sanchez-Curbelo
Journal:  World J Urol       Date:  2020-07-21       Impact factor: 4.226

Review 8.  Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA).

Authors:  James L Liu; Kevin Y Chu; Andrew T Gabrielson; Run Wang; Landon Trost; Gregory Broderick; Kelvin Davies; Gerald Brock; John Mulhall; Ranjith Ramasamy; Trinity J Bivalacqua
Journal:  Sex Med       Date:  2021-05-14       Impact factor: 2.491

Review 9.  Low-intensity shock wave therapy for the treatment of vasculogenic erectile dysfunction: a narrative review of technical considerations and treatment outcomes.

Authors:  Pedro Simoes de Oliveira; Matthew J Ziegelmann
Journal:  Transl Androl Urol       Date:  2021-06

10.  Evaluation of immediate and short-term efficacy of DualStim therapy with and without intracavernosal umbilical cord-derived Wharton's jelly in patients with erectile dysfunction: Study protocol for a randomized controlled trial.

Authors:  Ashim Gupta; Hugo C Rodriguez; Kristin Delfino; Howard J Levy; Saadiq F El-Amin; Richard Gaines
Journal:  Contemp Clin Trials Commun       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.